Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD
Completed · Phase 2 · Has a placebo group
Conditions studied: Anhedonia, Major Depressive Disorder
In brief
To evaluate the efficacy of NBI-1065846 compared with placebo on improving symptoms of anhedonia in participants with major depressive disorder (MDD).
Key facts
- Study ID
- NCT05165394
- Run by
- Neurocrine Biosciences
- People needed
- 93
- Starts
- 2021-11-30
- Expected to finish
- 2023-09-13
- Last updated by the study team
- 2024-07-31
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Neurocrine Clinical Site — Birmingham, Alabama, United States
- Neurocrine Clinical Site — Garden Grove, California, United States
- Neurocrine Clinical Site — Lemon Grove, California, United States
- Neurocrine Clinical Site — Orange, California, United States
- Neurocrine Clinical Site — Riverside, California, United States
- Neurocrine Clinical Site — San Diego, California, United States
- Neurocrine Clinical Site — San Francisco, California, United States
- Neurocrine Clinical Site — Orlando, Florida, United States
- Neurocrine Clinical Site — Pensacola, Florida, United States
- Neurocrine Clinical Site — Winter Park, Florida, United States
- Neurocrine Clinical Site — Atlanta, Georgia, United States
- Neurocrine Clinical Site — Chicago, Illinois, United States
- Neurocrine Clinical Site — Skokie, Illinois, United States
- Neurocrine Clinical Site — Saint Charles, Missouri, United States
- Neurocrine Clinical Site — Raleigh, North Carolina, United States
- Neurocrine Clinical Site — Columbus, Ohio, United States
- Neurocrine Clinical Site — Oklahoma City, Oklahoma, United States
- Neurocrine Clinical Site — Dallas, Texas, United States
- Neurocrine Clinical Site — Friendswood, Texas, United States
- Neurocrine Clinical Site — Houston, Texas, United States
- Neurocrine Clinical Site — Murray, Utah, United States
- Neurocrine Clinical Site — Everett, Washington, United States
- Neurocrine Clinical Site — San Juan, Puerto Rico
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.